Systematic review / meta-analysis / 2020
Dietary interventions including PUFAs and antioxidants show uncertain or little to no effect on multiple sclerosis relapses or disability progression.
A Cochrane systematic review evaluated 30 trials covering PUFA supplementation, antioxidants, dietary programs, and other supplements for multiple sclerosis. Comparing PUFAs with MUFAs showed very uncertain evidence regarding relapses (RR 1.02, 95% CI 0.88 to 1.20; 3 studies, 217 participants) and low-certainty evidence of little to no difference in global impression of deterioration (RR 0.85, 95% CI 0.71 to 1.03; 4 studies, 542 participants). Antioxidant supplementation compared to placebo also showed little to no difference in relapses (RR 0.98, 95% CI 0.59 to 1.64; 4 studies, 345 participants) and very uncertain effects on EDSS change (MD -0.19, 95% CI -0.49 to 0.11; 6 studies, 490 participants). All included trials had at least one methodological issue leading to unknown or high risk of bias.
- Study type
- Systematic review and meta-analysis of RCTs/CCTs
- Who was studied
- Adults with multiple sclerosis across 30 trials (Europe, North America, Middle East)
- What was measured
- Relapses, disability progression (EDSS), MRI activity, safety/adverse events
THE PAPER
Dietary interventions for multiple sclerosis-related outcomes.
Parks NE, Jackson-Tarlton CS, Vacchi L, Merdad R, Johnston BC. Cochrane Database Syst Rev, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.